Indian Anastrozole Exporters: Complete Supplier Ranking with Market Share — 158 Manufacturers (2026) — TransData Nexus

Q: Who is the largest anastrozole supplier from India?

INTAS PHARMACEUTICALS LIMITED is the largest anastrozole exporter from India with a 84.7% market share and export value of $93.8M.

Q: How many anastrozole suppliers are there in India?

There are 158 active anastrozole exporters in India, collectively shipping $110.7M worth of anastrozole across 2,238 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top anastrozole suppliers from India?

The top 5 anastrozole suppliers from India — INTAS PHARMACEUTICALS LIMITED, ZYDUS LIFESCIENCES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, NATCO PHARMA LIMITED — together control 96.4% of total anastrozole export value from India.

Suresh Sormare

Anastrozole

India Pharmaceutical Trade Intelligence

$110.7M158 Suppliers99 CountriesHS 30049099

ExportsIndia → UNITED STATES92.3%India → BRAZIL1.9%

ImportsUNITED STATES → India$10.5M ISRAEL → India$2.0M

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: EVERSANA LIFE

Anastrozole Suppliers from India (2026) — 158 Exporters, $110.7M Market | TransData Nexus | TransData Nexus

Who Exports Anastrozole from India — 158 Suppliers Behind a $110.7M Market

India's anastrozole export market is supplied by 158 active exporters who collectively shipped $110.7M across 2,238 shipments. INTAS PHARMACEUTICALS LIMITED leads with a 84.7% market share, followed by ZYDUS LIFESCIENCES LIMITED and EUGIA PHARMA SPECIALITIES LIMITED. The top 5 suppliers together control 96.4% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Anastrozole Suppliers & Exporters — 158 manufacturers, $110.7M export market, top destinations and formulations — Anastrozole supplier data — 158 exporters · $110.7M market · 2,238 shipmentsTransData Nexus · Indian Customs Data

Top Anastrozole Exporters from India — Ranked by Export Value

INTAS PHARMACEUTICALS LIMITED is the leading anastrozole exporter from India, holding a 84.7% share of the $110.7M market across 2,238 shipments from 158 exporters. The top 5 suppliers — INTAS PHARMACEUTICALS LIMITED, ZYDUS LIFESCIENCES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, NATCO PHARMA LIMITED — collectively control 96.4% of total export value, indicating a highly concentrated market. Individual shares are: INTAS PHARMACEUTICALS LIMITED (84.7%), ZYDUS LIFESCIENCES LIMITED (3.2%), EUGIA PHARMA SPECIALITIES LIMITED (3.2%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (2.8%), NATCO PHARMA LIMITED (2.4%).

Top Anastrozole Exporters from India

Ranked by export value · 158 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Anastrozole Exporters from India — Ranked by Export Value. 158 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Anastrozole — Export Intelligence Video

Visual overview of India's anastrozole supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's anastrozole pharmaceutical supplier landscape — $110.7M in total trade, 158 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Anastrozole exporters

Certification and compliance status for top Anastrozole suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Zydus Lifesciences Limited	Warning Letter, August 20	Yes, as of May 26, 2	Yes	59 approvals as of September 2023	Received FDA warning letter in August 2024; holds WHO-GMP certification since Ma
Eugia Pharma Specialities Limited	Warning Letter, August 20	Unknown	Unknown	14 approvals as of September 2023	Received FDA warning letter in August 2024; 14 ANDA approvals by September 2023.
Sun Pharmaceutical Industries Limited	Warning Letter, June 2024	Unknown	Unknown	10 approvals as of September 2023	Received FDA warning letter in June 2024; 10 ANDA approvals by September 2023.
Natco Pharma Limited	Warning Letter, April 202	Unknown	Unknown	4 approvals as of September 2023	Received FDA warning letter in April 2024; 4 ANDA approvals by September 2023.
Cadila Pharmaceuticals Limited	Warning Letter, March 201	Yes	Yes	Unknown	Received FDA warning letter in March 2014; holds WHO-GMP and EU GMP certificatio
Intas Pharmaceuticals Limited	Warning Letter, December	Yes	Yes	Unknown	Received FDA warning letter in December 2022; holds WHO-GMP and EU GMP certifica
Jodas Expoim Private Limited	Unknown	Yes	Yes	Unknown	Holds WHO-GMP and EU GMP certifications; no FDA warning letters found.
Globela Pharma Private Limited	Unknown	Yes	Unknown	Unknown	Holds WHO-GMP certification; no FDA warning letters found.

TransData Nexus reviewed the regulatory standing of 8 leading Anastrozole exporters from India. 0 hold US FDA facility approvals, 5 maintain WHO-GMP certification, and 4 are EU GMP compliant. 6 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Anastrozole sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for pharmaceutical manufacturing, particularly in active pharmaceutical ingredients (APIs). The city hosts Genome Valley, India's first biotech cluster, which accommodates over 200 life sciences companies, including major players like Dr. Reddy’s Laboratories and Aurobindo Pharma. This concentration of expertise and infrastructure makes Hyderabad a strategic location for sourcing APIs essential for Anastrozole production.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its robust pharmaceutical formulations industry. Ahmedabad is home to leading companies such as INTAS PHARMACEUTICALS LIMITED and Zydus Lifesciences Limited, both significant contributors to Anastrozole exports. Vadodara complements this with a strong manufacturing base, housing numerous pharmaceutical units that specialize in finished formulations. The synergy between these cities provides a comprehensive ecosystem for the production and export of pharmaceutical products.

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Anastrozole exporters from India

March 2025

M&A

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million

Sun Pharma announced the acquisition of Checkpoint Therapeutics, a U.S.-based immunotherapy and targeted oncology treatment company, for $355 million. This strategic move aims to enhance Sun Pharma's oncology portfolio and expand its presence in the U.S. market. - IMPACT: This acquisition is expected to strengthen Sun Pharma's position in the oncology sector, potentially leading to increased resources and focus on related products, including Anastrozole.

Impact: This acquisition is expected to strengthen Sun Pharma's position in the oncology sector, potentially leading to increased resources and focus on related products, including Anastrozole.

June 2025

M&A

Zydus Lifesciences Limited — Zydus acquires Agenus' CDMO business and partners on commercialization

Zydus Lifesciences acquired the Contract Development and Manufacturing Organization (CDMO) business of Agenus, including two biologics manufacturing sites in Emeryville and Berkeley. Additionally, Zydus partnered with Agenus to commercialize their molecules in India. - IMPACT: This acquisition and partnership may enhance Zydus' manufacturing capabilities and product offerings, potentially impacting the production and export of Anastrozole.

Common Questions — Anastrozole Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which anastrozole supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, INTAS PHARMACEUTICALS LIMITED leads with 209 recorded shipments worth $93.8M. ZYDUS LIFESCIENCES LIMITED (111 shipments) and EUGIA PHARMA SPECIALITIES LIMITED (116 shipments) are also established high-volume exporters.

Q How many anastrozole manufacturers are there in India?

India has 158 active anastrozole exporters with a combined export market of $110.7M across 2,238 shipments to 99 countries. The top 5 suppliers hold 96.4% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for anastrozole from India?

Average FOB unit price: $2.43 per unit, ranging from $0.01 to $100.00. Average shipment value: $49.5K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Anastrozole

Anastrozole

Who Exports Anastrozole from India — 158 Suppliers Behind a $110.7M Market

Top Anastrozole Exporters from India — Ranked by Export Value

Top Anastrozole Exporters from India

Related Analysis

Need Details?

Anastrozole — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million

Zydus Lifesciences Limited — Zydus acquires Agenus' CDMO business and partners on commercialization

Common Questions — Anastrozole Suppliers from India

Q Which anastrozole supplier from India is the most reliable for bulk orders?

Q How many anastrozole manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for anastrozole from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Zydus Lifesciences Limited — Zydus receives USFDA approval for prostate cancer drug

Analysis Methodology